CCIA
IDYA icon

Campbell & Co Investment Adviser’s IDEAYA Biosciences IDYA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-24,834
Closed -$872K – 1207
2024
Q2 		$872K Sell
24,834
-27,735
-53% -$1.1M 0.07% 422
2024
Q1 		$2.31M Sell
52,569
-8,657
-14% -$372K 0.2% 113
2023
Q4 		$2.18M Buy
61,226
+29,536
+93% +$882K 0.2% 113
2023
Q3 		$855K Buy
31,690
+10,506
+50% +$266K 0.1% 322
2023
Q2 		$498K Buy
+21,184
New +$436K 0.09% 440

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Campbell & Co Investment Adviser's IDYA Position: Q3 2024 in Review

Campbell & Co Investment Adviser sold out of IDEAYA Biosciences (IDYA) in Q3 2024, closing a stake of 24,834 shares — an estimated $872K sold.

Campbell & Co Investment Adviser first reported a position in IDYA in Q2 2023 and held it in 5 quarters. The position peaked at $2.31M in Q1 2024. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

  • Campbell & Co Investment Adviser reported no remaining IDEAYA Biosciences position as of Q3 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 24,834 IDEAYA Biosciences shares in Q3 2024, an estimated $872K.
  • Campbell & Co Investment Adviser first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's IDEAYA Biosciences position peaked at $2.31M in Q1 2024.
  • 209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2024, filed 12 Nov 2024.